Liver cirrhosis is a serious condition. It damages the liver over time. Common causes include alcohol, hepatitis, and fatty ...

Many people with compensated cirrhosis have no symptoms or only mild issues like tiredness or bloating. Research published in The New England Journal of Medicine has shown that people with compensated ...

“Lower thyroid-hormone receptor-beta (THR-β) activity in the liver is predictive of hepatic decompensation 2 in patients with MASH, so there is a strong mechanistic rationale supporting the potential ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious complications like ascites and hepatic encephalopathy.

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American ...

Disappearance of Decompensated Liver Cirrhosis Episodes After Treatment with Can-Fite's Namodenoson Provided by GlobeNewswire Feb 18, 2025 4:00am ...

Decompensated liver cirrhosis, an advanced stage of cirrhosis often associated with liver failure, currently has no approved therapeutic options other than liver transplantation. At 20 months into ...

Primary Source JAMA Source Reference: Pose E, et al "Simvastatin and rifaximin in decompensated cirrhosis: a randomized clinical trial" JAMA 2025; DOI: 10.1001/jama.2024.27441.

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity Bariatric surgery favorably influences progression of cirrhosis Date: January 27 ...